Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Dalotuzumab (Anti-IGF1R / CD221) For research use only.
Not for use in humans.

Dalotuzumab (Anti-IGF1R / CD221)

Synonyms: MK-0646; h7C10

Dalotuzumab (Anti-IGF1R / CD221) is a recombinant humanized monoclonal antibody directed against the insulin-like growth factor 1 receptor (IGF1R) with potential antineoplastic activity. MW : 146.78 KD.

Dalotuzumab (Anti-IGF1R / CD221)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Dalotuzumab (Anti-IGF1R / CD221) is a recombinant humanized monoclonal antibody directed against the insulin-like growth factor 1 receptor (IGF1R) with potential antineoplastic activity. MW : 146.78 KD.

Product Details

CAS No. 1005389-60-5
Molecular Weight 146.78
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Dalotuzumab (Anti-IGF1R / CD221) | Dalotuzumab (Anti-IGF1R / CD221) supplier | purchase Dalotuzumab (Anti-IGF1R / CD221) | Dalotuzumab (Anti-IGF1R / CD221) cost | Dalotuzumab (Anti-IGF1R / CD221) manufacturer | order Dalotuzumab (Anti-IGF1R / CD221) | Dalotuzumab (Anti-IGF1R / CD221) distributor